13F-HR filed by STEMPOINT CAPITAL LP
STEMPOINT CAPITAL LP filed this 13F-HR for the quarter ended 2025-06-30, filed 2025-08-14, with 53 holding rows worth $311,575,076.
- Accession
- 0001420506-25-002033
- Filer
- CIK 1952142
- Filed
- 2025-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2025
A holdings report, 54 entries on the cover page, a total value of $311,575,076 stated on the cover page (in dollars after the unit check, H1), rows summing to $311,575,076 with VALUE read as dollars as filed, 13F file number 028-23724. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 2,372,634 | $22,219,717 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 1,300,860 | $20,813,760 | dollars as filed | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 528,115 | $18,705,833 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 1,265,672 | $16,630,930 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 52,694 | $15,947,312 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 266,094 | $13,996,544 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 201,452 | $13,265,614 | dollars as filed | |
| CIDARA THERAPEUTICS INC | 171757206 | COM NEW | 266,774 | $12,994,562 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 176,752 | $11,168,959 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 351,124 | $10,042,498 | dollars as filed | |
| DENALI THERAPEUTICS INC COM | 24823R105 | Stock | 707,915 | $9,903,731 | dollars as filed | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 270,144 | $9,587,411 | dollars as filed | |
| GERON CORP | 374163103 | COM | 6,649,244 | $9,375,434 | dollars as filed | |
| ZAI LAB LTD ADR | 98887Q104 | ADR | 250,438 | $8,757,817 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 631,586 | $8,551,043 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 572,615 | $7,982,253 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 601,781 | $6,782,072 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 116,779 | $6,231,327 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 61,578 | $6,197,210 | dollars as filed | |
| SURROZEN INC | 86889P208 | COMMON STOCK | 686,539 | $6,137,659 | dollars as filed | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 900,338 | $5,852,197 | dollars as filed | |
| LENZ THERAPEUTICS INC | 52635N103 | COM | 183,912 | $5,390,461 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 59,828 | $4,564,876 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 386,790 | $4,372,661 | dollars as filed | |
| VISTAGEN THERAPEUTICS INC | 92840H400 | COM | 2,413,254 | $4,117,380 | dollars as filed | |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 84,466 | $3,668,358 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 165,885 | $3,486,903 | dollars as filed | |
| PROTARA THERAPEUTICS INC | 74365U107 | COM STK | 1,143,677 | $3,465,341 | dollars as filed | |
| HELIX ACQUISITION CORP II | G4444H101 | CL A ORD SHS | 315,812 | $3,290,856 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 329,254 | $3,098,280 | dollars as filed | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 205,672 | $2,883,521 | dollars as filed | |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 644,654 | $2,875,157 | dollars as filed | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 1,203,941 | $2,781,104 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 152,652 | $2,764,528 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 174,754 | $2,465,779 | dollars as filed | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 4,672 | $2,452,800 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 54,630 | $2,358,923 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 89,933 | $2,077,452 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 200,785 | $2,037,968 | dollars as filed | |
| MBX BIOSCIENCES INC COM | 55287L101 | Stock | 141,021 | $1,609,050 | dollars as filed | |
| PERCEPTIVE CAPITAL SOLUTIONS | G70077105 | CL A ORD SHS | 150,000 | $1,593,000 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 32,255 | $1,356,323 | dollars as filed | |
| GH RESEARCH PLC ORDINARY SHARES | G3855L106 | Stock | 100,826 | $1,229,069 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 208,800 | $1,069,056 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 16,770 | $926,761 | dollars as filed | |
| TECTONIC THERAPEUTIC INC | 878972108 | COMMON STOCK | 40,000 | $794,800 | dollars as filed | |
| ADC THERAPEUTICS SA | H0036K147 | COMMON STOCK | 283,286 | $759,206 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 7,407 | $700,554 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 87,748 | $671,272 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 915,000 | $617,625 | dollars as filed | call |
| MIND MEDICINE MINDMED INC | 60255C885 | COM NEW | 90,852 | $589,629 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 100,000 | $310,000 | dollars as filed | call |
| GERON CORP | 374163103 | COM | 300,000 | $52,500 | dollars as filed | call |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-25-002033 | this filing | 2025-08-14 | acceptance time not in the bulk data set |